HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naomi Rahimi-Levene Selected Research

Naomi Rahimi-Levene Research Topics

Disease

9B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
04/2019 - 11/2003
5COVID-19
06/2022 - 09/2020
3Infections
10/2021 - 11/2003
3Thrombocytopenia (Thrombopenia)
01/2021 - 10/2012
3Anemia
11/2020 - 10/2012
2Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2021 - 05/2013
2Pneumonia (Pneumonitis)
09/2020 - 03/2018
2Thrombosis (Thrombus)
01/2006 - 11/2005
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2022
1Hematologic Neoplasms (Hematological Malignancy)
10/2021
1Cytokine Release Syndrome
08/2021
1Autoimmune Diseases (Autoimmune Disease)
01/2021
1Rare Diseases (Rare Disease)
01/2021
1Heart Diseases (Heart Disease)
01/2021
1acquired Thrombotic thrombocytopenic purpura
01/2021
1Residual Neoplasm
02/2018
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2014
1Lymphadenopathy
07/2014
1Paraproteinemias (Monoclonal Gammopathy)
07/2014
1Fibrosis (Cirrhosis)
05/2013
1Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
05/2013
1Cytopenia
05/2013
1Splenomegaly
10/2012
1Inflammation (Inflammations)
08/2012
1Hypercholesterolemia
08/2012
1Neoplasms (Cancer)
02/2006
1Carcinoma (Carcinomatosis)
02/2006
1Activated Protein C Resistance (APC Resistance)
11/2005
1Hemorrhage
02/2005
1Hemolysis
03/2002

Drug/Important Bio-Agent (IBA)

4Rituximab (Mabthera)FDA Link
04/2019 - 11/2014
4fludarabineIBA
04/2019 - 11/2003
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2019 - 05/2015
2BNT162 VaccineIBA
10/2021 - 01/2021
2VaccinesIBA
10/2021 - 01/2021
2Immunoglobulin G (IgG)IBA
09/2020 - 07/2014
2beta 2-Microglobulin (beta 2 Microglobulin)IBA
07/2014 - 10/2012
2plasma protein Z (protein Z)IBA
01/2006 - 11/2005
1Fluorescein (Funduscein)FDA LinkGeneric
01/2022
1COVID-19 VaccinesIBA
10/2021
1AntigensIBA
09/2021
1ABO Blood-Group SystemIBA
09/2021
1CytokinesIBA
08/2021
1AlbuminsIBA
08/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1AntibodiesIBA
11/2020
1Complement System Proteins (Complement)IBA
01/2019
1Hemoglobins (Hemoglobin)IBA
03/2018
1Dihydrotachysterol (AT 10)IBA
05/2015
1Immunoglobulin A (IgA)IBA
07/2014
1Immunoglobulins (Immunoglobulin)IBA
07/2014
1Immunoglobulin M (IgM)IBA
07/2014
1Reticulin (Reticular Fiber)IBA
05/2013
1Inosine Triphosphate (ITP)IBA
05/2013
1Interleukin-2 Receptor alpha SubunitIBA
10/2012
1Interleukin-2 Receptors (IL 2 Receptor)IBA
10/2012
1ADP-ribosyl Cyclase 1IBA
10/2012
1Plasminogen Activators (Plasminogen Activator)IBA
08/2012
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
08/2012
1InterleukinsIBA
08/2012
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2012
1Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
11/2005
1Anticardiolipin AntibodiesIBA
11/2005
1Alkylating AgentsIBA
11/2003

Therapy/Procedure

4Therapeutics
08/2021 - 11/2003
2Drug Therapy (Chemotherapy)
11/2014 - 11/2003
2Prostatectomy (Retropubic Prostatectomy)
02/2006 - 02/2005
1Blood Transfusion (Blood Transfusions)
06/2022
1Plasma Exchange
08/2021
1Artificial Respiration (Mechanical Ventilation)
09/2020
1Length of Stay
03/2018
1Lymph Node Excision (Lymph Node Dissection)
02/2006
1Liver Transplantation
03/2002